It's particularly this last part which is most appealing as the letter is to the "Annals of Medicine and Surgery" signed by eight authors which I would take as being practioner based.
"In other Sofdra news, in a letter to the editors of the journal Annals of Medicine and Surgery, eight authors reiterate the usefulness of Sofdra to treat underarm excessive sweating noting its targeted nature (localized to the skin of the underarms), its effectiveness, and its more limited side effects (as compared to those of oral medications.) Their call to action is that more people should be made aware of this treatment option and that it should be made more affordable and accessible. Cost effectiveness studies of Sofdra compared to other treatments, they say, could be especially helpful."
GLTAH
BOT Price at posting:
30.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)